BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8851499)

  • 1. Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists.
    van Hooft JA; Vijverberg HP
    Br J Pharmacol; 1996 Mar; 117(5):839-46. PubMed ID: 8851499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full and partial agonists induce distinct desensitized states of the 5-HT3 receptor.
    van Hooft JA; Vijverberg HP
    J Recept Signal Transduct Res; 1997; 17(1-3):267-77. PubMed ID: 9029495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
    Bartrup JT; Newberry NR
    J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells.
    Sepúlveda MI; Lummis SC; Martin IL
    Br J Pharmacol; 1991 Oct; 104(2):536-40. PubMed ID: 1797317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native serotonin 5-HT3 receptors expressed in Xenopus oocytes differ from homopentameric 5-HT3 receptors.
    van Hooft JA; Kreikamp AP; Vijverberg HP
    J Neurochem; 1997 Sep; 69(3):1318-21. PubMed ID: 9282959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital.
    Barann M; Göthert M; Bönisch H; Dybek A; Urban BW
    Neuropharmacology; 1997; 36(4-5):655-64. PubMed ID: 9225291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohols potentiate the function of 5-HT3 receptor-channels on NCB-20 neuroblastoma cells by favouring and stabilizing the open channel state.
    Zhou Q; Verdoorn TA; Lovinger DM
    J Physiol; 1998 Mar; 507 ( Pt 2)(Pt 2):335-52. PubMed ID: 9518697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells.
    Lummis SC; Sepúlveda MI; Kilpatrick GJ; Baker J
    Eur J Pharmacol; 1993 Oct; 243(1):7-11. PubMed ID: 8253126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol and trichloroethanol alter gating of 5-HT3 receptor-channels in NCB-20 neuroblastoma cells.
    Lovinger DM; Sung KW; Zhou Q
    Neuropharmacology; 2000 Feb; 39(4):561-70. PubMed ID: 10728877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors.
    Hussy N; Lukas W; Jones KA
    J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):311-23. PubMed ID: 7537814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
    Niemeyer MI; Lummis SC
    Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxyindole slows desensitization of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells.
    Kooyman AR; van Hooft JA; Vijverberg HP
    Br J Pharmacol; 1993 Feb; 108(2):287-9. PubMed ID: 7680589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of the 5-HT3B subunit alters the functional properties of 5-HT3 receptors native to neuroblastoma cells.
    Stewart A; Davies PA; Kirkness EF; Safa P; Hales TG
    Neuropharmacology; 2003 Feb; 44(2):214-23. PubMed ID: 12623220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT3-like receptors in the rat medial prefrontal cortex: further pharmacological characterization.
    Edwards E; Hampton E; Ashby CR; Zhang J; Wang RY
    Brain Res; 1996 Sep; 733(1):21-30. PubMed ID: 8891244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RS-056812-198: partial agonist on native and antagonist on cloned 5-HT3 receptors.
    Van Hooft JA; Vijverberg HP
    Eur J Pharmacol; 1997 Mar; 322(2-3):229-33. PubMed ID: 9098692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.
    Lankiewicz S; Lobitz N; Wetzel CH; Rupprecht R; Gisselmann G; Hatt H
    Mol Pharmacol; 1998 Feb; 53(2):202-12. PubMed ID: 9463477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the membrane current mediated by serotonin 5-HT3 receptors in cultured mouse neuroblastoma cells.
    Neijt HC; Plomp JJ; Vijverberg HP
    J Physiol; 1989 Apr; 411():257-69. PubMed ID: 2482354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a domain affecting agonist potency of meta-chlorophenylbiguanide in 5-HT3 receptors.
    Mochizuki S; Miyake A; Furuichi K
    Eur J Pharmacol; 1999 Mar; 369(1):125-32. PubMed ID: 10204690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 5-HT3 receptor cation channels by ifenprodil in excised patches of N1E-115 cells.
    Barann M; Bönisch H; Urban BW; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):145-52. PubMed ID: 9749998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.